Simplex Trading’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-16,100
| Closed | -$764K | – | 8394 |
|
|
2025
Q3 | $764K | Sell |
16,100
-54,800
| -77% | -$2.65M | ﹤0.01% | 3326 |
|
|
2025
Q2 | $3.78M | Buy |
70,900
+5,800
| +9% | +$264K | ﹤0.01% | 1578 |
|
|
2025
Q1 | $2.63M | Buy |
65,100
+16,000
| +33% | +$678K | ﹤0.01% | 1779 |
|
|
2024
Q4 | $1.36M | Buy |
49,100
+16,300
| +50% | +$494K | ﹤0.01% | 2548 |
|
|
2024
Q3 | $941K | Sell |
32,800
-9,700
| -23% | -$253K | ﹤0.01% | 2965 |
|
|
2024
Q2 | $997K | Sell |
42,500
-21,900
| -34% | -$468K | ﹤0.01% | 2911 |
|
|
2024
Q1 | $1.63M | Sell |
64,400
-13,600
| -17% | -$327K | ﹤0.01% | 2610 |
|
|
2023
Q4 | $1.82M | Buy |
78,000
+45,900
| +143% | +$905K | ﹤0.01% | 2444 |
|
|
2023
Q3 | $1.62M | Buy |
32,100
+25,900
| +418% | +$1.21M | ﹤0.01% | 2256 |
|
|
2023
Q2 | $289K | Sell |
6,200
-14,800
| -70% | -$678K | ﹤0.01% | 3900 |
|
|
2023
Q1 | $803K | Sell |
21,000
-2,900
| -12% | -$129K | ﹤0.01% | 2793 |
|
|
2022
Q4 | $1.31M | Sell |
23,900
-5,600
| -19% | -$240K | ﹤0.01% | 2215 |
|
|
2022
Q3 | $1M | Buy |
29,500
+29,000
| +5,800% | +$444K | ﹤0.01% | 2630 |
|
|
2022
Q2 | $4K | Buy |
500
+400
| +400% | +$4.17K | ﹤0.01% | 8917 |
|
|
2022
Q1 | $1K | Sell |
100
-500
| -83% | -$8.76K | ﹤0.01% | 10020 |
|
|
2021
Q4 | $12K | Sell |
600
-1,000
| -63% | -$22.2K | ﹤0.01% | 8845 |
|
|
2021
Q3 | $40K | Hold |
1,600
| – | – | ﹤0.01% | 7778 |
|
|
2021
Q2 | $39K | Buy |
1,600
+1,571
| +5,417% | +$44.1K | ﹤0.01% | 7935 |
|
|
2021
Q1 | $84K | Sell |
29
-73
| -72% | -$2.21K | ﹤0.01% | 5967 |
|
|
2020
Q4 | $263K | Buy |
+102
| New | +$2.84K | ﹤0.01% | 4247 |
|
|
2020
Q3 | – | Sell |
-1
| Closed | -$2K | – | 7702 |
|
|
2020
Q2 | $2K | Sell |
1
-12
| -92% | -$274 | ﹤0.01% | 7214 |
|
|
2020
Q1 | $27K | Buy |
+13
| New | +$279 | ﹤0.01% | 5694 |
|
Other funds holding AKRO
Simplex Trading's AKRO Position: Q4 2025 in Review
Simplex Trading sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 4,565 shares — an estimated $216K sold.
Simplex Trading first reported a position in AKRO in Q2 2020 and held it in 15 quarters. The position peaked at $2.67M in Q3 2022. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.
- Simplex Trading reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 4,565 Akero Therapeutics shares in Q4 2025, an estimated $216K.
- Simplex Trading first reported a position in Akero Therapeutics in Q2 2020 and held it in 15 quarters.
- Simplex Trading's Akero Therapeutics position peaked at $2.67M in Q3 2022.
- 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.